Emergent Biosolutions Inc (EBS)
Stock-Based Compensation
$6.90M
Quarterly · Period ending: · USD
EBS Stock-Based Compensation
Latest reported$6.90Mperiod ending
Latest reported$6.90Mperiod ending
EBS Quarterly Stock-Based Comp ($723.00K → $6.90M)
Quarterly stock-based compensation
High-resolution chart · PNG
EBS stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,900,000 | |
| 1,900,000 | |
| 5,300,000 | |
| 4,800,000 | |
| 4,600,000 | |
| 1,500,000 | |
| 4,300,000 | |
| 2,300,000 | |
| 5,500,000 | |
| 5,900,000 | |
| 4,000,000 | |
| 4,000,000 | |
| 8,300,000 | |
| 6,800,000 | |
| 11,700,000 | |
| 11,200,000 | |
| 12,300,000 | |
| 9,900,000 | |
| 10,100,000 | |
| 10,400,000 | |
| 11,400,000 | |
| 10,500,000 | |
| 10,000,000 | |
| 10,000,000 | |
| 24,400,000 | |
| 6,600,000 | |
| 5,700,000 | |
| 6,100,000 | |
| 8,100,000 | |
| 6,800,000 | |
| 6,536,000 | |
| 5,000,000 | |
| 4,400,000 | |
| 7,300,000 | |
| 3,408,000 | |
| 3,787,000 | |
| 3,734,000 | |
| 4,284,000 | |
| 3,950,000 | |
| 4,582,000 | |
| 4,748,000 | |
| 5,197,000 | |
| 4,046,000 | |
| 4,012,000 | |
| 3,992,000 | |
| 3,798,000 | |
| 3,375,000 | |
| 3,439,000 | |
| 3,365,000 | |
| 2,650,000 | |
| 2,779,000 | |
| 2,741,000 | |
| 2,742,000 | |
| 2,976,000 | |
| 2,698,000 | |
| 2,992,000 | |
| 2,713,000 | |
| 2,712,000 | |
| 2,828,000 | |
| 2,761,000 | |
| 2,709,000 | |
| 2,441,000 | |
| 1,857,000 | |
| 1,843,000 | |
| 1,841,000 | |
| 1,522,000 | |
| 1,362,000 | |
| 1,395,000 | |
| 1,390,000 | |
| 860,000 | |
| 2,510,000 | |
| 0 | |
| 756,000 | |
| 230,000 | |
| 2,541,000 | |
| 0 | |
| 0 | |
| 529,000 | |
| 723,000 |